Zobrazeno 1 - 10
of 72
pro vyhledávání: '"D. E. Joshua"'
Autor:
Najah T. Nassif, Narelle Woodland, Derek N.J. Hart, S Yang, Simon McAuliffe, Phoebe Joy Ho, D. E. Joshua, Ross Brown, Cheryl L. Paul, John Gibson, Claire Weatherburn, Alberto Catalano, Hayley Suen
A pilot study was performed to investigate the use of digital PCR (dPCR) to detect minimal residual disease (MRD) in patients with multiple myeloma. dPCR allows greater quantitative specificity in PCR reactions by performing multiple, minute PCR reac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97ba8d827522b061dab24a00c0866630
https://hdl.handle.net/10453/37600
https://hdl.handle.net/10453/37600
Autor:
O.M. Garson, Kenneth F. Bradstock, Max Wolf, D. E. Joshua, Ray M. Lowenthal, Anthony J. Dodds, David D.F. Ma, R. P. Hermann, Jane P. Matthews, James F. Bishop, Ralph Cobcroft, Arno Enno, Graham A.R. Young, KM Taylor, Jeff Szer, Surender Juneja, E. A. Gillett
Publikováno v:
British Journal of Haematology. 113:727-736
Patterns of failure were studied in two consecutive randomized trials of intensified induction therapy carried out by the Australian Leukaemia Study Group (ALSG) between 1984 and 1991 to determine the impact of dose intensification. Patients received
Publikováno v:
British Journal of Haematology. 105:795-798
The treatment of human immunodeficiency virus (HIV)-related lymphoma is beset by a number of therapeutic limitations. High-dose chemotherapy followed by peripheral blood stem cell transplantation (PBSCT) for relapsed disease is one option, but may be
Publikováno v:
Leukemia & Lymphoma. 31:379-384
Presentation of tumour antigen by malignant cells not expressing costimulatory molecules is considered to be a major cause of the failure of the host's immune response against tumours. This study has determined the expression of the B7 family of cost
Publikováno v:
Bone Marrow Transplantation. 20:205-210
A flow cytometric technique has been developed to detect individual plasma cells in PBSC harvests and to establish light chain restriction as a surrogate marker of their clonality. Plasma cells were identified by high intensity CD38 (CD38++) and cyto
Autor:
Richard M. Fox, D. E. Joshua, A Gillett, Max Wolf, Kenneth F. Bradstock, Ga Young, Jane P. Matthews, A Enno, J F Bishop, Jeff Szer
Publikováno v:
Blood. 87:1710-1717
High-dose cytarabine (ara-c) may overcome cytarabine resistance in leukemic blasts. It has been used as a successful salvage and in postremission therapy but not as initial induction treatment. Patients aged 15 to 60 years, presenting with newly diag
Autor:
Derek N.J. Hart, Harry J. Iland, D. E. Joshua, Jennifer Hsu, Robin Gasiorowski, Michael S. Papadimitrious, John Gibson, Christian E Bryant, Phoebe Joy Ho, Ross Brown, Phillip D. Fromm, Georgina J. Clark, Daniel Orellana
Publikováno v:
Cytotherapy. 18:S100
Publikováno v:
Internal medicine journal. 43(5)
Like the acute leukaemias, the chronic leukaemias are broadly classified according to their cell lineage of origin. Chronic myeloid leukaemia and chronic lymphocytic leukaemia are the most common disease entities within the myeloid and lymphoid linea
Publikováno v:
Praxis. 101(13)
Autor:
Henry M. Kronenberg, Graham A.R. Young, Johnson L, D. E. Joshua, Harry J. Iland, Paul C. Vincent, John Gibson, MacLeod C, R. Benn, L. Snowdon
Publikováno v:
Australian and New Zealand Journal of Medicine. 24:374-377
Background: Bacterial infection is a major cause of morbidity and mortality in neutropenic patients. Aims: (1) To review patterns and trends in bacterial infections in three cohorts of febrile neutropenic patients managed by a single unit over a seve